130 related articles for article (PubMed ID: 37232574)
1. Long noncoding RNA TUG1 promotes proliferation, migration and cisplatin resistance in oral squamous cell carcinoma.
Liu S; Wang W; Ye L; Liu C; Xiao W; Gao J
Acta Biochim Biophys Sin (Shanghai); 2023 May; 55(8):1323-1326. PubMed ID: 37232574
[No Abstract] [Full Text] [Related]
2. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
[TBL] [Abstract][Full Text] [Related]
3. LncRNA BANCR promotes oral squamous cell carcinoma progression via regulating Rab1A signaling.
Li W; Xu X; Ma Z; Shen P; Cheng B; Xia J; Li Y
J Oral Pathol Med; 2023 Sep; 52(8):727-737. PubMed ID: 37433101
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA TFAP2A-AS1 promotes oral squamous cell carcinoma cell growth and movement via competitively binding miR-1297 and regulating TFAP2A expression.
Yang K; Niu Y; Cui Z; Jin L; Peng S; Dong Z
Mol Carcinog; 2022 Sep; 61(9):865-875. PubMed ID: 35730908
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA TUG1 regulates the development of oral squamous cell carcinoma through sponging miR-524-5p to mediate DLX1 expression as a competitive endogenous RNA.
Liu S; Liu LH; Hu WW; Wang M
J Cell Physiol; 2019 Nov; 234(11):20206-20216. PubMed ID: 30980391
[TBL] [Abstract][Full Text] [Related]
6. Immunity-related long noncoding RNA WDFY3-AS2 inhibited cell proliferation and metastasis through Wnt/β-catenin signaling in oral squamous cell carcinoma.
Lin X; Ding JM; Zheng XZ; Chen JG
Arch Oral Biol; 2023 Mar; 147():105625. PubMed ID: 36657277
[TBL] [Abstract][Full Text] [Related]
7. LncRNA HOXD-AS1 promotes oral squamous cell carcinoma by sponging miR-203a-5p.
Zhang Y; Wang F; Yu Y
Oral Dis; 2023 May; 29(4):1505-1512. PubMed ID: 35152529
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of lncRNA IGF2BP2-AS1 inhibits proliferation and migration of oral squamous cell carcinoma cells via the Wnt/β-catenin pathway.
Tong S; Wang X; Guo X; Lu Z
J Oral Pathol Med; 2022 Mar; 51(3):272-280. PubMed ID: 34637162
[TBL] [Abstract][Full Text] [Related]
9. The expression and functional role of a FOXC1 related mRNA-lncRNA pair in oral squamous cell carcinoma.
Kong XP; Yao J; Luo W; Feng FK; Ma JT; Ren YP; Wang DL; Bu RF
Mol Cell Biochem; 2014 Sep; 394(1-2):177-86. PubMed ID: 24889262
[TBL] [Abstract][Full Text] [Related]
10. miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling.
Lu M; Wang C; Chen W; Mao C; Wang J
DNA Cell Biol; 2018 Apr; 37(4):381-388. PubMed ID: 29364705
[TBL] [Abstract][Full Text] [Related]
11. LncRNA HOXA11-AS Promotes Proliferation and Cisplatin Resistance of Oral Squamous Cell Carcinoma by Suppression of miR-214-3p Expression.
Wang X; Li H; Shi J
Biomed Res Int; 2019; 2019():8645153. PubMed ID: 31275988
[TBL] [Abstract][Full Text] [Related]
12. LINC00629, a KLF10-responsive lncRNA, promotes the anticancer effects of apigenin by decreasing Mcl1 stability in oral squamous cell carcinoma.
Shi C; Ma C; Ren C; Li N; Liu X; Zhang Y; Wang Y; Li X; Lv P; Han C; Li X
Aging (Albany NY); 2022 Nov; 14(22):9149-9166. PubMed ID: 36445338
[TBL] [Abstract][Full Text] [Related]
13. lncRNA LINC01296 Promotes Oral Squamous Cell Carcinoma Development by Binding with SRSF1.
Zhang Y; Wang A; Zhang X; Wang X; Zhang J; Ma J
Biomed Res Int; 2021; 2021():6661520. PubMed ID: 34195277
[TBL] [Abstract][Full Text] [Related]
14. FOXD1-AS1 upregulates FOXD1 to promote oral squamous cell carcinoma progression.
Ma Y; Han J; Luo X
Oral Dis; 2023 Mar; 29(2):604-614. PubMed ID: 34403535
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-485-5p targets keratin 17 to regulate oral cancer stemness and chemoresistance via the integrin/FAK/Src/ERK/β-catenin pathway.
Jang TH; Huang WC; Tung SL; Lin SC; Chen PM; Cho CY; Yang YY; Yen TC; Lo GH; Chuang SE; Wang LH
J Biomed Sci; 2022 Jun; 29(1):42. PubMed ID: 35706019
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA BANCR promotes proliferation and migration in oral squamous cell carcinoma via MAPK signaling pathway.
Yao C; Kong F; Zhang S; Wang G; She P; Zhang Q
J Oral Pathol Med; 2021 Mar; 50(3):308-315. PubMed ID: 31654433
[TBL] [Abstract][Full Text] [Related]
17. LncRNA LINC00152 promotes oral squamous cell carcinoma growth via enhancing Upstream Transcription Factor 1 mediated Mitochondrial Ribosomal Protein L52 transcription.
Zou X; Hu X; He F; Zhang M; Kong X; Rui S; Liu Y; Wang L; Zheng X; Liu J; Li Z; Luo H
J Oral Pathol Med; 2022 May; 51(5):454-463. PubMed ID: 34664331
[TBL] [Abstract][Full Text] [Related]
18. METTL3/14 and IL-17 signaling contribute to CEBPA-DT enhanced oral cancer cisplatin resistance.
Qiao X; Zhu L; Song R; Shang C; Guo Y
Oral Dis; 2023 Apr; 29(3):942-956. PubMed ID: 34807506
[TBL] [Abstract][Full Text] [Related]
19. SNHG17/miR-384/ELF1 axis promotes cell growth by transcriptional regulation of CTNNB1 to activate Wnt/β-catenin pathway in oral squamous cell carcinoma.
Qiao C; Qiao T; Yang S; Liu L; Zheng M
Cancer Gene Ther; 2022 Jan; 29(1):122-132. PubMed ID: 33531646
[TBL] [Abstract][Full Text] [Related]
20. Long non‑coding RNA fer‑1‑like family member 4 serves as a tumor suppressor in laryngeal squamous cell carcinoma cells via regulating the AKT/ERK signaling pathway.
Jiao L; Liu S; Liu L; Hao P; Gong Z; Yan Z; Xiang Y
Mol Med Rep; 2020 Dec; 22(6):5304-5312. PubMed ID: 33174027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
